Published in Semin Clin Neuropsychiatry on April 01, 2002
Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. JAMA (2008) 6.60
Early childhood factors associated with the development of post-traumatic stress disorder: results from a longitudinal birth cohort. Psychol Med (2006) 2.57
Personality, adrenal steroid hormones, and resilience in maltreated children: a multilevel perspective. Dev Psychopathol (2007) 1.48
Polymorphisms in CRHR1 and the serotonin transporter loci: gene x gene x environment interactions on depressive symptoms. Am J Med Genet B Neuropsychiatr Genet (2010) 1.42
Gene-environment interactions: early life stress and risk for depressive and anxiety disorders. Psychopharmacology (Berl) (2011) 1.30
An abbreviated version of the Connor-Davidson Resilience Scale (CD-RISC), the CD-RISC2: psychometric properties and applications in psychopharmacological trials. Psychiatry Res (2007) 1.19
An intricate dance: Life experience, multisystem resiliency, and rate of telomere decline throughout the lifespan. Soc Personal Psychol Compass (2012) 1.01
Epigenetics of early child development. Front Psychiatry (2011) 1.01
Cortisol levels in relation to maternal interaction and child internalizing behavior in preterm and full-term children at 18 months corrected age. Dev Psychobiol (2010) 0.97
Early life trauma and attachment: immediate and enduring effects on neurobehavioral and stress axis development. Front Endocrinol (Lausanne) (2014) 0.97
Abnormal cortisol awakening response predicts worse cognitive function in patients with first-episode psychosis. Psychol Med (2010) 0.96
Stress-induced changes in extracellular dopamine and serotonin in the medial prefrontal cortex and dorsal hippocampus of prenatally malnourished rats. Brain Res (2007) 0.94
Postnatal development of electrophysiological properties of principal neurons in the rat basolateral amygdala. J Physiol (2012) 0.92
Differential regulation of the serotonin 1 A transcriptional modulators five prime repressor element under dual repression-1 and nuclear-deformed epidermal autoregulatory factor by chronic stress. Neuroscience (2009) 0.91
Differential distribution of serotonin receptor subtypes in BNST(ALG) neurons: modulation by unpredictable shock stress. Neuroscience (2012) 0.89
Inflammatory biomarker profiles of mental disorders and their relation to clinical, social and lifestyle factors. Soc Psychiatry Psychiatr Epidemiol (2014) 0.89
Impact of repeated procedural pain-related stress in infants born very preterm. Pediatr Res (2014) 0.87
Cortisol levels in former preterm children at school age are predicted by neonatal procedural pain-related stress. Psychoneuroendocrinology (2014) 0.87
Sex-dependent diversity in ventral tegmental dopaminergic neurons and developmental programing: A molecular, cellular and behavioral analysis. Neuroscience (2014) 0.87
Neonatal stress-induced affective changes in adolescent Wistar rats: early signs of schizophrenia-like behavior. Front Behav Neurosci (2014) 0.86
Socially isolated mice exhibit a blunted homeostatic sleep response to acute sleep deprivation compared to socially paired mice. Brain Res (2012) 0.86
Chronic non-invasive corticosterone administration abolishes the diurnal pattern of tph2 expression. Psychoneuroendocrinology (2011) 0.85
A putatively functional polymorphism in the HTR2C gene is associated with depressive symptoms in white females reporting significant life stress. PLoS One (2014) 0.84
Targeting memory processes with drugs to prevent or cure PTSD. Expert Opin Investig Drugs (2012) 0.84
Total flavonoids extracted from xiaobuxin-tang on the hyperactivity of hypothalamic-pituitary-adrenal axis in chronically stressed rats. Evid Based Complement Alternat Med (2011) 0.82
Potential programming of dopaminergic circuits by early life stress. Psychopharmacology (Berl) (2010) 0.82
Negative life events and corticotropin-releasing-hormone receptor1 gene in recurrent major depressive disorder. Sci Rep (2013) 0.81
An Overview of Psychological and Neurobiological Mechanisms by which Early Negative Experiences Increase Risk of Mood Disorders. J Can Acad Child Adolesc Psychiatry (2011) 0.81
Serotonin Transporter (5-HTTLPR) Genotype and Childhood Trauma are Associated with Individual Differences in Decision Making. Front Genet (2011) 0.80
Early and later life stress alter brain activity and sleep in rats. PLoS One (2013) 0.80
Global and gene-specific DNA methylation alterations in the adolescent amygdala and hippocampus in an animal model of caregiver maltreatment. Behav Brain Res (2015) 0.80
Prenatal corticosterone and adolescent URB597 administration modulate emotionality and CB1 receptor expression in mice. Psychopharmacology (Berl) (2013) 0.79
Circuit to construct mapping: a mathematical tool for assisting the diagnosis and treatment in major depressive disorder. Front Psychiatry (2015) 0.79
Glucocorticoid programing of the mesopontine cholinergic system. Front Endocrinol (Lausanne) (2013) 0.78
Sugar Consumption Produces Effects Similar to Early Life Stress Exposure on Hippocampal Markers of Neurogenesis and Stress Response. Front Mol Neurosci (2016) 0.77
Family Economic Hardship, Corticotropin-Releasing Hormone Receptor Polymorphisms, and Depressive Symptoms in Rural African-American Youths. J Adolesc Health (2015) 0.76
Childhood maltreatment as a risk factor for COPD: findings from a population-based survey of Canadian adults. Int J Chron Obstruct Pulmon Dis (2016) 0.75
Late-Onset Cognitive Impairments after Early-Life Stress Are Shaped by Inherited Differences in Stress Reactivity. Front Cell Neurosci (2017) 0.75
The influence of early life sexual abuse on oxytocin concentrations and premenstrual symptomatology in women with a menstrually related mood disorder. Biol Psychol (2015) 0.75
Hypothalamic-pituitary-adrenal axis functioning and dysfunctional attitude in depressed patients with and without childhood neglect. BMC Psychiatry (2014) 0.75
The Val66Met brain-derived neurotrophic factor gene variant interacts with early pain exposure to predict cortisol dysregulation in 7-year-old children born very preterm: Implications for cognition. Neuroscience (2015) 0.75
Vulnerability or Sensitivity to the Environment? Methodological Issues, Trends, and Recommendations in Gene-Environment Interactions Research in Human Behavior. Front Psychiatry (2017) 0.75
Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. JAMA (2008) 6.60
Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry (2005) 4.81
Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions. Nat Neurosci (2012) 4.71
Influence of child abuse on adult depression: moderation by the corticotropin-releasing hormone receptor gene. Arch Gen Psychiatry (2008) 4.65
The role of dopamine in the pathophysiology of depression. Arch Gen Psychiatry (2007) 4.51
The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. Am J Psychiatry (2005) 4.45
The link between childhood trauma and depression: insights from HPA axis studies in humans. Psychoneuroendocrinology (2008) 4.35
Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress. Am J Psychiatry (2006) 3.33
Are mood disorders and obesity related? A review for the mental health professional. J Clin Psychiatry (2004) 3.26
Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology (2002) 3.24
Childhood trauma associated with smaller hippocampal volume in women with major depression. Am J Psychiatry (2002) 3.05
Early life programming and neurodevelopmental disorders. Biol Psychiatry (2010) 2.93
Depressive symptoms and viral clearance in patients receiving interferon-alpha and ribavirin for hepatitis C. Brain Behav Immun (2005) 2.52
Long-term consequences of neonatal rearing on central corticotropin-releasing factor systems in adult male rat offspring. Neuropsychopharmacology (2005) 2.35
Reduced glucocorticoid receptors: consequence or cause of depression? Trends Endocrinol Metab (2006) 2.26
Neurobiological and psychiatric consequences of child abuse and neglect. Dev Psychobiol (2010) 2.17
Depression, desperation, and suicidal ideation in college students: results from the American Foundation for Suicide Prevention College Screening Project at Emory University. Depress Anxiety (2008) 2.16
Epidemiology of comorbid coronary artery disease and depression. Biol Psychiatry (2003) 2.13
Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment. Biol Psychiatry (2003) 2.05
Importance of studying the contributions of early adverse experience to neurobiological findings in depression. Neuropsychopharmacology (2004) 2.03
Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy. Am J Psychiatry (2003) 1.90
Anterior cingulate activation and error processing during interferon-alpha treatment. Biol Psychiatry (2005) 1.80
Long-term behavioural and molecular alterations associated with maternal separation in rats. Eur J Neurosci (2007) 1.79
The relationship of depression and diabetes: pathophysiological and treatment implications. Psychoneuroendocrinology (2011) 1.74
The role of early adverse experience and adulthood stress in the prediction of neuroendocrine stress reactivity in women: a multiple regression analysis. Depress Anxiety (2002) 1.72
The dexamethasone/corticotropin-releasing factor test in men with major depression: role of childhood trauma. Biol Psychiatry (2007) 1.71
Alterations in diurnal cortisol rhythm and acoustic startle response in nonhuman primates with adverse rearing. Biol Psychiatry (2005) 1.65
Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination. Biol Psychiatry (2002) 1.65
Basal ganglia hypermetabolism and symptoms of fatigue during interferon-alpha therapy. Neuropsychopharmacology (2007) 1.63
Hypercortisolemia and depression. Psychosom Med (2005) 1.60
Long-term adaptations in glucocorticoid receptor and mineralocorticoid receptor mRNA and negative feedback on the hypothalamo-pituitary-adrenal axis following neonatal maternal separation. Biol Psychiatry (2004) 1.59
Effects of risperidone augmentation in patients with treatment-resistant depression: Results of open-label treatment followed by double-blind continuation. Neuropsychopharmacology (2006) 1.59
Depression during pegylated interferon-alpha plus ribavirin therapy: prevalence and prediction. J Clin Psychiatry (2005) 1.58
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases. J Clin Psychiatry (2007) 1.54
Effects of interferon-alpha on rhesus monkeys: a nonhuman primate model of cytokine-induced depression. Biol Psychiatry (2007) 1.51
Neurobiology of posttraumatic stress disorder. CNS Spectr (2009) 1.48
Self-reported depressive symptom measures: sensitivity to detecting change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatients. Neuropsychopharmacology (2005) 1.47
International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol. Trials (2011) 1.46
Measuring the severity of depression and remission in primary care: validation of the HAMD-7 scale. CMAJ (2005) 1.42
Polymorphisms in CRHR1 and the serotonin transporter loci: gene x gene x environment interactions on depressive symptoms. Am J Med Genet B Neuropsychiatr Genet (2010) 1.42
Cerebrospinal fluid corticotropin-releasing factor and perceived early-life stress in depressed patients and healthy control subjects. Neuropsychopharmacology (2004) 1.41
Effect of Childhood Trauma on Adult Depression and Neuroendocrine Function: Sex-Specific Moderation by CRH Receptor 1 Gene. Front Behav Neurosci (2009) 1.41
Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT Study. J Clin Psychiatry (2007) 1.40
Atypical antipsychotic administration during late pregnancy: placental passage and obstetrical outcomes. Am J Psychiatry (2007) 1.38
Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity. Biol Psychiatry (2004) 1.32
Parental depression: animal models of an adverse life event. Am J Psychiatry (2002) 1.29
National Depressive and Manic-Depressive Association consensus statement on the use of placebo in clinical trials of mood disorders. Arch Gen Psychiatry (2002) 1.29
Pituitary-adrenal responses to standard and low-dose dexamethasone suppression tests in adult survivors of child abuse. Biol Psychiatry (2004) 1.26
Depression, antidepressants, and neurogenesis: a critical reappraisal. Neuropsychopharmacology (2011) 1.25
The neurobiological toll of child abuse and neglect. Trauma Violence Abuse (2009) 1.25
An interactive web-based method of outreach to college students at risk for suicide. J Am Coll Health (2008) 1.23
Post-traumatic stress disorder: the neurobiological impact of psychological trauma. Dialogues Clin Neurosci (2011) 1.22
Partial response and nonresponse to antidepressant therapy: current approaches and treatment options. J Clin Psychiatry (2002) 1.19
Persistent central nervous system effects of an adverse early environment: clinical and preclinical studies. Physiol Behav (2003) 1.17
The neural correlates of social anxiety disorder and response to pharmacotherapy. Neuropsychopharmacology (2006) 1.16
Prediction of antidepressant response to milnacipran by norepinephrine transporter gene polymorphisms. Am J Psychiatry (2004) 1.14
Developing novel treatments for mood disorders: accelerating discovery. Biol Psychiatry (2002) 1.13
Depression and bipolar support alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in children and adolescents. J Am Acad Child Adolesc Psychiatry (2003) 1.10
Decreased cortical representation of genital somatosensory field after childhood sexual abuse. Am J Psychiatry (2013) 1.10
Comparing the effects of antidepressants: consensus guidelines for evaluating quantitative reviews of antidepressant efficacy. Neuropsychopharmacology (2005) 1.10
Chronic overexpression of corticotropin-releasing factor from the central amygdala produces HPA axis hyperactivity and behavioral anxiety associated with gene-expression changes in the hippocampus and paraventricular nucleus of the hypothalamus. Psychoneuroendocrinology (2011) 1.09
Personalized medicine in psychiatry: problems and promises. BMC Med (2013) 1.09
Cape Town consensus on posttraumatic stress disorder. CNS Spectr (2009) 1.09
Consensus statement update on posttraumatic stress disorder from the international consensus group on depression and anxiety. J Clin Psychiatry (2004) 1.08
Elevated cerebrospinal fluid substance p concentrations in posttraumatic stress disorder and major depression. Am J Psychiatry (2006) 1.07
Predictors of remission in depression to individual and combined treatments (PReDICT): study protocol for a randomized controlled trial. Trials (2012) 1.06
Efficacy and tolerability of controlled-release and immediate-release paroxetine in the treatment of depression. J Clin Psychiatry (2002) 1.06
Divalproex in the treatment of impulsive aggression: efficacy in cluster B personality disorders. Neuropsychopharmacology (2003) 1.05
Neurotensin: role in psychiatric and neurological diseases. Peptides (2006) 1.05
The corticotropin-releasing factor1 receptor antagonist R121919 attenuates the behavioral and endocrine responses to stress. J Pharmacol Exp Ther (2003) 1.04
Etiology of depression: genetic and environmental factors. Psychiatr Clin North Am (2012) 1.04
Neurobiology of early life stress: rodent studies. Semin Clin Neuropsychiatry (2002) 1.03
Advances in the treatment of depression. NeuroRx (2006) 1.03
The effects of child abuse and neglect on cognitive functioning in adulthood. J Psychiatr Res (2012) 1.01
The diagnosis of major depression in patients with cancer: a comparative approach. Psychosomatics (2006) 1.01
The neurobiology of anxiety disorders: brain imaging, genetics, and psychoneuroendocrinology. Psychiatr Clin North Am (2009) 1.00
Association of polymorphisms in genes regulating the corticotropin-releasing factor system with antidepressant treatment response. Arch Gen Psychiatry (2010) 1.00
A randomized, placebo-controlled trial of risperidone augmentation for patients with difficult-to-treat unipolar, non-psychotic major depression. J Psychiatr Res (2008) 1.00
Neurotensin-deficient mice have deficits in prepulse inhibition: restoration by clozapine but not haloperidol, olanzapine, or quetiapine. J Pharmacol Exp Ther (2005) 0.99
Pharmacology of valproate. Psychopharmacol Bull (2003) 0.99
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) study: outcomes from the acute and continuation phases. Biol Psychiatry (2007) 0.99
Synchronized maternal-infant elevations of primate CSF CRF concentrations in response to variable foraging demand. CNS Spectr (2005) 0.99
Early life stress combined with serotonin 3A receptor and brain-derived neurotrophic factor valine 66 to methionine genotypes impacts emotional brain and arousal correlates of risk for depression. Biol Psychiatry (2010) 0.98
The neurobiology of bipolar disorder. Am J Med Genet C Semin Med Genet (2003) 0.98
A double-blind, multicenter, parallel-group study of paroxetine, desipramine, or placebo in breast cancer patients (stages I, II, III, and IV) with major depression. J Clin Psychiatry (2006) 0.97
DSM-5: a collection of psychiatrist views on the changes, controversies, and future directions. BMC Med (2013) 0.97
The neurobiology of anxiety disorders: brain imaging, genetics, and psychoneuroendocrinology. Clin Lab Med (2010) 0.96
Exploratory structural equation modeling of resting-state fMRI: applicability of group models to individual subjects. Neuroimage (2009) 0.96
Ketamine-xylazine-acepromazine anesthesia and postoperative recovery in rats. J Am Assoc Lab Anim Sci (2006) 0.96
Lithium, but not fluoxetine or the corticotropin-releasing factor receptor 1 receptor antagonist R121919, increases cell proliferation in the adult dentate gyrus. J Pharmacol Exp Ther (2011) 0.96
Increased responsiveness of presumed 5-HT cells to citalopram in adult rats subjected to prolonged maternal separation relative to brief separation. Psychopharmacology (Berl) (2004) 0.96
The pharmacokinetics of sertraline excretion into human breast milk: determinants of infant serum concentrations. J Clin Psychiatry (2003) 0.96
Early-life stress, corticotropin-releasing factor, and serotonin transporter gene: a pilot study. Psychoneuroendocrinology (2010) 0.96
Cortisol concentrations in 12- to 18-month-old infants: stability over time, location, and stressor. Biol Psychiatry (2003) 0.95
Aripiprazole augmentation of antidepressants for the treatment of partially responding and nonresponding patients with major depressive disorder. J Clin Psychiatry (2005) 0.94
The interaction of serotonin transporter gene polymorphisms and early adverse life events on vulnerability for major depression. Curr Psychiatry Rep (2006) 0.94
A novel transgenic mouse for gene-targeting within cells that express corticotropin-releasing factor. Biol Psychiatry (2010) 0.93
Serotonin transporter: a potential substrate in the biology of suicide. Neuropsychopharmacology (2002) 0.92